Lessiani Gianfranco, Falco Angela, Nicolucci Elvira, Rolandi Giancarlo, Davì Giovanni
Villa Serena Hospital, Pescara, Italy.
J Thromb Thrombolysis. 2009 Apr;27(3):348-51. doi: 10.1007/s11239-008-0222-1. Epub 2008 Apr 6.
Factor XII deficiency is associated with increased risk for both arterial and venous thrombosis. We describe a case of DVT involving superficial femoral and popliteal vein occurred following total hip replacement and despite prophylaxis with low molecular weight heparin in a subject with previous acute myocardial infarction (AMI). Tests of haemostasis documented a slightly prolonged activated partial thromboplastin time (APTT) (45'') due to mild factor XII deficiency (clotting activity 32%). A therapeutic dose of enoxaparin was started, together with warfarin therapy. The patient was advised to continue oral anticoagulation indefinitely. Although cases of both venous and arterial thrombosis in carriers of severe factor XII deficiency have been already reported, to our knowledge this is the first case in the literature occurred in a carrier of partial factor XII deficiency. In conclusion, factor XII deficiency should be suspected if a patient presents with recurrent arterial and/or venous thrombosis and prolonged APTT. If this defect is diagnosed, in the presence of a history of thrombotic events, lifelong anticoagulation could be considered.
因子 XII 缺乏与动脉和静脉血栓形成的风险增加有关。我们描述了一例在全髋关节置换术后发生股浅静脉和腘静脉深静脉血栓形成(DVT)的病例,该患者既往有急性心肌梗死(AMI)病史,尽管使用了低分子量肝素进行预防。止血检查显示,由于轻度因子 XII 缺乏(凝血活性 32%),活化部分凝血活酶时间(APTT)略有延长(45 秒)。开始使用治疗剂量的依诺肝素,并同时进行华法林治疗。建议患者无限期继续口服抗凝治疗。虽然已经报道过严重因子 XII 缺乏携带者发生静脉和动脉血栓形成的病例,但据我们所知,这是文献中首例发生在部分因子 XII 缺乏携带者中的病例。总之,如果患者出现复发性动脉和/或静脉血栓形成以及 APTT 延长,应怀疑因子 XII 缺乏。如果诊断出这种缺陷,在有血栓形成事件病史的情况下,可以考虑终身抗凝治疗。